Gentian Lluri is a Cardiology physician affiliated with University of California, Los Angeles. OpenAlex indexes 92 publications with 1,275 citations (h-index 17).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
100 Medical Plaza Driveway Suite 630
Los Angeles, CA 900957232
Telephone
310-794-9629Registry record last updated 26 Nov 2018.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Edwards Lifesciences CorporationProgram year20253 payments
- Actelion Pharmaceuticals US, Inc.Program year20242 payments
- Actelion Pharmaceuticals US, Inc.Program year20234 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
87.4%Statin20.2%Atorvastatin Calcium52%Rosuvastatin Calcium35%Crestor6%Pravastatin Sodium4%Simvastatin4%Part D<11 patientsBeta blocker19.3%Carvedilol39%Metoprolol Tartrate35%Metoprolol Succinate21%Atenolol5%Part D<11 patients+ 12 more classes in this area
Blood & clotting
9.8%Factor Xa inhibitor7.7%Eliquis78%Xarelto22%Part D<11 patientsP2Y12 inhibitor2.1%Clopidogrel67%Brilinta33%Part D<11 patientsMetabolism & gastrointestinal
2%Potassium supplement1.3%Potassium Chloride100%Part D<11 patientsProton pump inhibitor0.7%Omeprazole100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Intrahepatic Transcriptomics Differentiate Advanced Fibrosis and Clinical Outcomes in Adults With Fontan Circulation
Journal of the American College of Cardiology
2024 - Hepatocellular carcinoma in survivors after Fontan operation: a case–control study
European Heart Journal
2023 - Clinical and invasively-measured predictors of high exercise capacity in Fontan patients
International Journal of Cardiology
2023 - Delivery Timing and Associated Outcomes in Pregnancies With Maternal Congenital Heart Disease at Term
Journal of the American Heart Association
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Dennis Slamon, MD
University of California, Los Angeles
Richard Casaburi, MD
University of California, Los Angeles
Robert Modlin, MD
University of California, Los Angeles
Zev Wainberg, MD
University of California, Los Angeles
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”